Molecular and functional characterization of the endothelial ATP-sensitive potassium channel by Aziz, Q et al.






Molecular and functional characterization of the endothelial 
ATP-sensitive potassium channel 
 
Qadeer Aziz, Yiwen Li, Naomi Anderson, Leona Ojake, Elena Tsisanova, Andrew Tinker# 
 
The Heart Centre, William Harvey Research Institute, Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK 
 
Running Title: KATP in vascular endothelium 
 
#Corresponding Author; a.tinker@qmul.ac.uk, Tel: 02078825783 Fax: 02078823408, The Heart 
Centre, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, 
Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.  
 
Keywords: Endothelium, ion channel, potassium channel, ATP sensitive, hypoxia, vascular biology, 
 
ABSTRACT 
 ATP-sensitive potassium (KATP) 
channels are widely expressed in the 
cardiovascular system where they regulate a 
range of biological activities by linking cellular 
metabolism with membrane excitability. KATP 
channels in vascular smooth muscle have a well-
defined role in regulating vascular tone. KATP 
channels are also thought to be expressed in 
vascular endothelial cells (ECs), but their 
presence and function in this context is less clear. 
As a result, we aimed to investigate the 
molecular composition and physiological role of 
endothelial KATP channels. We first generated 
mice with an endothelial specific deletion of the 
channel subunit Kir6.1 (eKO) using cre-loxP 
technology. Data from qRT-PCR, patch-clamp, 
ex-vivo coronary perfusion Langendorff heart 
experiments and endothelial cell Ca2+ imaging 
comparing eKO and wild type mice show that 
Kir6.1-containing KATP channels are indeed 
present in vascular endothelium. An increase in 
intracellular [Ca2+], which is central to changes 
in endothelial function such as mediator release, 
at least partly contributes to the endothelium-
dependent vasorelaxation induced by the KATP 
channel opener pinacidil. The absence of Kir6.1 
did not elevate basal coronary perfusion pressure 
in eKO mice. However, vasorelaxation was 
impaired during hypoxia in the coronary 
circulation and this resulted in greater cardiac 
injury during ischaemia-reperfusion. The 
response to adenosine receptor stimulation was 
impaired in eKO mice in single cells in patch-
clamp recordings and in the intact coronary 
circulation. Our data support the existence of an 
endothelial KATP channel that contains Kir6.1, is 
involved in vascular reactivity in the coronary 




 ATP-sensitive potassium channels (KATP) 
are expressed throughout the body including in 
the brain, pancreas and cardiovascular system. 
Their ability to open in response to declining 
ATP and\or increasing ADP allows them to 
couple cellular metabolism with membrane 
excitability (1). As a result, they play an 
important role in the regulation of a range of 
biological activities such as insulin release, 
vascular tone and adaptation to stresses such as 
exercise and ischaemia (1). Structurally, KATP 
channels form as hetero-octomeric complexes 
consisting of four pore-forming inward rectifier 
Kir6.x subunits (Kir6.1 or Kir6.2) and four large 
regulatory sulphonylurea receptor subunits 
(SUR1, SUR2A or SUR2B) (1). These subunits 
associate in various tissue-specific combinations 
to form functional KATP channels and these 
currents can have distinct pharmacological and 
electrophysiological properties.  
 KATP channels in the vasculature have 
been implicated in the regulation of tone and 
blood flow (2-6). The function and molecular 
identity of the vascular smooth muscle cell KATP 
channel has been the subject of intensive 
research over the past 25 years and has been 
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aided by the development of a number of 
genetically modified murine models (1,7). 
Global deletion of Kir6.1 and SUR2 were 
initially used to explore the role of KATP 
channels and ascertain the contribution of these 
subunits to the KATP current in smooth muscle 
cells. Both knockout (KO) mice had a similar 
hypertensive phenotype consistent with previous 
in vitro electrophysiological data suggesting a 
role for vascular smooth muscle KATP channels 
in the regulation of resting membrane potential 
and vascular tone (2,3). Although informative, a 
global genetic deletion of Kir6.1 or SUR2 is not 
selective for the smooth muscle channel and 
potentially channels in the endothelium, nervous 
system and heart might all be affected and 
contribute to the observed phenotype. Recently, 
a tissue-specific targeting strategy has 
substantially clarified the role of KATP channels 
in smooth muscle (1,4). Mice expressing a 
smooth muscle-specific gain of function mutant 
KATP channel have low blood pressure (4). In 
addition, we developed a mouse model in which 
it was possible to conditionally delete Kir6.1 in 
smooth muscle cells. Mice with a conditional 
vascular smooth muscle KATP deletion lacked a 
functional KATP current in smooth muscle cells 
and were moderately hypertensive consistent 
with Kir6.1 being the pore-forming subunit of 
these channels and Kir6.1-containing channels 
playing a role in the regulation of blood pressure 
(5). However, the specific-deletion of Kir6.1 did 
not fully recapitulate the global Kir6.1 KO 
phenotype suggesting that Kir6.1-containing 
channels in other tissues are also important in 
the regulation of vascular tone (5,6). 
 Potentially, KATP channels in many cell 
types could be involved in the control of 
vascular function, but given its control over 
vasoactive substances, the endothelium is the 
most likely candidate. Indeed, based mainly on 
pharmacological evidence, KATP channels in the 
endothelium have been shown to exist and 
contribute to the regulation of blood flow in the 
coronary vasculature (8-13). The vasodilatory 
actions of adenosine may be in part due to its 
effect on endothelial KATP channels (14). 
Pharmacological approaches however suffer 
from a lack of tissue selectivity especially given 
the prominent expression of KATP channels in 
striated and smooth muscle. The expression of a 
dominant-negative Kir6.1 in endothelium leads 
to the increased release of endothelin-1 and 
increased basal coronary perfusion pressure (15). 
However, such dominant negative approaches 
are not subunit-specific as Kir6.1 and Kir6.2 
heteromultimerise and the high expression of 
such constructs can have off-target effects (16). 
Kir6.1 is thought to be the significant but not the 
only pore-forming subunit of the endothelial 
KATP channel, with Kir6.2 thought to also be 
involved (17). 
 Thus in this report, we investigate the 
role of Kir6.1 containing KATP channels in the 
endothelium on vascular function, particularly in 
the coronary circulation, by using cre-loxP 
technology to generate an endothelial-specific 
Kir6.1/Kir6.2 KO mouse model. We show that 
Kir6.1 is the likely pore-forming subunit of the 
vascular endothelial KATP channel. The channel 
is involved in vascular function and has an 




Kir6.1 expression is reduced in the endothelium 
from the aorta and mesenteric arteries of Kir6.1 
knockout mice - In our previous study we used 
endothelium denuded aorta and other blood 
vessels for expression and functional studies (5). 
We used cre-loxP technology to specifically 
delete Kir6.1 (Kcnj8) in endothelium ((5) and 
Figure 1A and B). To confirm the reduced 
expression of Kir6.1 (Kcnj8) in the endothelium 
of tie2cre+ Kir6.1(flx,flx) (eKO) mice, 
quantitative real-time PCR was performed on 
RNA isolated from the aorta and mesenteric 
arteries with and without endothelium (Fig. 1C 
and D). Kir6.1 expression was substantially 
reduced in endothelium-intact aorta (40%) and 
mesenteric arteries (40 %) from eKO mice 
compared with littermate control animals (WT) 
(n=6, P<0.01 and 0.001, respectively). In both 
vessel types where the endothelium had been 
denuded, Kir6.1 expression was reduced to a 
similar level in both the WT and eKO mice and 
was comparable to the amount of deletion 
observed in endothelium-intact vessels from the 
eKO mice (P>0.05). The expression of Kir6.2 
(Kcnj11) was not affected in either the intact 
aorta or mesenteric arteries in either mouse line 
(n=6, P>0.05). Interestingly, expression of the 
Kir6.2 transcript was also unchanged in the 
denuded vessels (n=6, P>0.05). SUR2 (Abcc9) 
expression was significantly reduced in the 
denuded aorta and mesenteric arteries of 
endothelium-specific Kir6.1 knockout mice 
suggesting SUR2 was the major endothelial 
SUR subunit (Figure 1C and D). However the 
effect of endothelial removal was more 
pronounced in the eKO mice suggesting perhaps 






































was not expressed in either aorta or mesenteric 
arteries (data not shown). 
KATP current is attenuated in acutely-isolated 
aortic endothelial cells from endothelium-
specific Kir6.1 KO mice - To investigate the 
functional relevance of Kir6.1 deletion on the 
KATP current in the endothelium, whole-cell 
patch-clamp recordings were performed on 
acutely isolated aortic endothelial cells from WT 
and eKO mice (Figure 2). Endothelial cells from 
WT mice show a K+ selective current which was 
activated by the KATP opener pinacidil (P<0.05) 
and inhibited by the KATP blocker glibenclamide 
(Figure 2A, C and D). In contrast, currents from 
eKO endothelial cells lacked a response to 
pinacidil (P>0.05) or glibenclamide suggesting 
that the KATP current is absent or present at very 
low levels (Fig. 2B, C and D).  It is possible 
that deletion of Kir6.1 from endothelium may 
lead to changes in expression in smooth muscle 
cell KATP currents (SMCs). To see if this is the 
case, we subjected acutely isolated aortic 
smooth muscle cells from eKO mice to whole-
cell patch-clamp (Figure 2E-H). Both WT and 
eKO vascular SMCs showed a similar amplitude 
glibenclamide-sensitive current (P>0.05). 
Pinacidil-induced elevation of cytosolic [Ca2+] 
is absent in endothelium-specific Kir6.1 
knockout mice - Ca2+ is an important mediator of 
endothelial cell function including release of 
vasoactive species. To further characterise the 
specific deletion of Kir6.1 in the endothelium 
we studied mouse aortic valve (MAV) leaflets 
using an imaging based approach to measure 
Ca2+ dynamics in the cytosol of endothelial cells 
(18). It is technically highly challenging to 
selectively image Ca2+ signals in endothelial 
cells in bloods vessels as endothelial cells are 
flat and there will be contamination of the 
endothelial fluorescent signal from overlying 
smooth muscle cells which will also take up 
Fluo-4 even using confocal microscopy. This 
methodology excludes the possibility of vascular 
smooth muscle cells contaminating the Ca2+ 
signal (Figure 3). In both WT and eKO MAV 
endothelial cells, Fluo-4 fluorescence was 
elevated to a similar extent (F/F0 ≈ 3.0) by the 
SERCA inhibitor, CPA (100 µM), which 
initiates Ca2+ entry through Ca2+ store depletion 
(P<0.001). Pinacidil (10 and 100 µM) also 
significantly increased cytosolic Ca2+ in a 
concentration-dependent manner in WT MAV 
endothelial cells (P<0.05 and P<0.001 compared 
to baseline), although it was smaller (F/F0 ≤ 1.5) 
than those induced by CPA. The pinacidil-
induced increase in cytosolic Ca2+ was 
completely inhibited by prior application of 10 
µmol/L glibenclamide. In contrast, in eKO 
MAV endothelial cells, pinacidil failed to 
significantly increase cytosolic Ca2+ from 
baseline levels (P>0.05). These data support the 
presence of Kir6.1 and its involvement in Ca2+ 
signalling in the endothelial cells of MAVs. 
Endothelial KATP channels in the coronary 
vasculature - To investigate the presence and 
role of Kir6.1-containing KATP channels in the 
endothelium of the coronary circulation we 
measured coronary perfusion pressure (CPP) at a 
constant flow rate. Basal CPP was higher in 
hearts from eKO mice compared with WT mice 
but this increase was not statistically significant 
(93.1±4.4 mmHg vs 103.5±6 mmHg, n=23, 
P>0.05). Pinacidil (10 μM) significantly reduced 
CPP in both WT and eKO mice (Figure 4), 
although the reduction of CPP in eKO (17%) 
mice was significantly less compared to WT 
(35%, P<0.05). Addition of glibenclamide (10 
μM) reversed the pinacidil-induced fall in CPP 
back to baseline Figure 4A-C). We also 
compared this with mice in which Kir6.1 is 
deleted from smooth muscle (see Experimental 
Procedures and (5)) and in this case the response 
to pinacidil was also reduced but not completely 
abolished (Figure 4). The basal CPP was not 
significantly different. 
Function of endothelial KATP channels in the 
coronary circulation - To examine the role of 
the endothelial KATP at times of metabolic stress, 
we exposed the coronary circulation to local 
hypoxia with a perfusate saturated with N2 and 
measured the change in CPP during that period. 
Both WT and eKO hearts responded with a 
significant drop in pressure, however the effect 
was much larger in WT (37%) hearts compared 
to eKO (10%) hearts (Figure 5A, P<0.01). In the 
smKO mice there was a trend to reduction in the 
hypoxic response (WT- 37%, eKO- 20%) 
though this was not statistically significant 
(Figure 5A).   
Additionally, hearts from all groups of 
mice were subjected to global ischaemia (no 
flow) followed by reperfusion. Staining of 
sections from these hearts with TTC revealed a 
greater infarcted area in Kir6.1 eKO (77%) 
hearts than in WT (56%) hearts (Figure 5B). 
Taken together, these data suggest that 
endothelial Kir6.1-containing KATP channels in 
the coronary circulation may have a protective 
role in the heart during ischaemia-reperfusion 
injury. Hearts from smKO mice (Figure 5C) also 
had an increase in infarcted area (P<0.05) 






































both the smooth muscle and endothelial KATP 
channel are important in limiting the ischaemic 
damage. In our hands there is no deletion of 
Kir6.1 in cardiac tissues using the sm22 cre and 
thus these effects likely derive from the deletion 
smooth muscle (5).   
Expression and role of Kir6.2 in vascular 
endothelium - The endothelium of blood vessels 
is postulated to express KATP channels 
containing Kir6.2 as well as Kir6.1. To test for 
this, we used a mouse model in which Kir6.2 
was selectively deleted from endothelium using 
a cre driven by the Tie2 promoter (see 
Experimental Procedures). Whole-cell patch-
clamp recordings from endothelial cells isolated 
from the aortas of WT and Kir6.2 eKO mice 
show that the amplitude of the pinacidil and 
glibenclamide-sensitive current is not affected 
by the ablation of Kir6.2 (Fig. 6A-C). Next, we 
investigated whether deletion of Kir6.2 in 
endothelium affected the function of the 
coronary circulation. Data from the Langendorf 
experiments show that hearts from WT and 
Kir6.2 eKO mice have similar basal CPP values 
suggesting Kir6.2-containing KATP channels are 
not involved in regulating basal vascular tone in 
the coronary circulation (Figure 6D). In addition, 
the pinacidil and hypoxia response in Kir6.2 
eKO mouse hearts was not significantly 
different from WT hearts (Figure 6E, P>0.05). 
Furthermore, there was no difference in infarct 
size between Kir6.2 eKO and WT hearts 
following ischaemia-reperfusion (Figure 6F, 
P>0.05). 
The effect of the adenosine receptor agonist, 
NECA, is diminished in endothelial cells and the 
coronary circulation in eKO mice. - A major 
mediator of the response to cellular ischaemia is 
thought to be adenosine release from 
compromised tissue which in turn activates 
adenosine receptors in vascular smooth muscle 
and endothelial cells. Thus we investigated if 
this was the case and isolated KATP currents in 
endothelial cells as described above. In WT 
endothelial cells, NECA, an adenosine receptor 
agonist not metabolised by adenosine deaminase, 
was able to activate K+ currents (P<0.01). In 
contrast, in endothelial cells from eKO mice no 
such increase of current was seen (Figure 7A-C). 
We also investigated changes in perfusion 
pressure in the coronary circulation in response 
to NECA. NECA induced a substantial fall in 
CPP (~42%) comparable to that of hypoxia. This 
response was significantly reduced in the eKO 
mice (~30%, P<0.05) (Figure 7D-E). 
 
DISCUSSION 
 The major findings in this study are that 
an endothelial KATP channel exists composed of 
Kir6.1 and likely SUR2B. Activation of the 
channel can promote Ca2+ entry into endothelial 
cells. In the coronary circulation, the channel 
contributes significantly to the vasodilation in 
response to hypoxia and loss of Kir6.1 in the 
endothelium increases cardiac injury after 
ischaemia reperfusion. The endothelial KATP 
channel responds to adenosine receptor 
activation and this regulation is impaired in eKO 
cells and blood vessels. In earlier studies, we 
and others have shown the important 
contribution of vascular smooth muscle KATP 
channels comprising the Kir6.1 subunit to blood 
vessel tone and the regulation of blood pressure 
(2-5). The location of the endothelium as a first 
point of contact for sensing circulatory changes, 
its ability to synthesize vasoactive mediators (19) 
and direct electrical coupling to vascular smooth 
muscle cells allow the endothelium to govern 
vascular smooth cell tone (20). To further 
understand the role of KATP channels in the 
vasculature we have used the cre-loxP system to 
create an endothelium-specific Kir6.1 knockout 
mouse model. In this study we particularly 
focused on establishing the presence of this 
channel and its potential role in vascular 
physiology. Our data show the significant 
contribution of Kir6.1-containing KATP channels 
to the current in the endothelium.  
 Though endothelial KATP currents have 
been shown in a number of vessels and species 
(8,9,11), the subunit composition of these 
channels was not systematically investigated 
except in one study where a heteromultimer of 
Kir6.1 and Kir6.2 was proposed using a human 
coronary endothelial cell line (17). We used a 
different approach by selectively deleting Kir6.1 
in murine endothelial cells. Our data show, 
Kir6.1 expression in the endothelium and 
transcriptomic analysis confirmed deletion of 
Kir6.1 in the eKO murine line. Functionally, 
whole-cell patch-clamp recordings using an 
intracellular solution favourable for activity of 
both Kir6.1 and Kir6.2 subunit containing KATP 
currents (0.1 mmol/L ATP/1 mmol/L ADP) 
from acutely isolated aortic endothelial cells 
confirmed the presence of a pinacidil and 
glibenclamide-sensitive current. This current 
was not detectable in endothelial cells from 
Kir6.1 eKO mice suggesting Kir6.1 as the main 
pore-forming subunit in endothelial cells in the 
aorta. Furthermore Ca2+ imaging studies of the 






































Kir6.1-containing KATP channels in vascular 
endothelium. Using mouse aortic valve leaflets 
allowed us to look at pure endothelial Ca2+ 
signalling without contamination from smooth 
muscle cells (18). We found that deletion of 
Kir6.1 from endothelium prevented the 
pinacidil-induced increase in cytoplasmic Ca2+. 
The increase in [Ca2+]i is likely because of KATP 
opening leading to membrane hyperpolarisation 
and as a result initiating a change in the 
electrochemical gradient favourable to Ca2+ ion 
influx from the extracellular space. In contrast to 
vascular smooth muscle cells, endothelial cells 
do not prominently express voltage-gated Ca2+ 
channels and Ca2+ entry occurs through transient 
receptor potential channels and store-operated 
entry (21). Changes in the response to Ca2+ 
store-depletion seem an unlikely mechanism as 
there was no difference in the effects of the 
SERCA inhibitor CPA between the lines. 
Finally, the effect of pinacidil on coronary 
perfusion pressure (CPP) was also reduced in 
eKO mice suggesting the presence of Kir6.1-
containing KATP channels in the mouse coronary 
circulation. The basal CPP was not significantly 
elevated in eKO hearts though there was a trend 
to an increase. This is in contrast to the finding 
in an endothelial-specific dominant-negative 
mouse model, where the CPP was substantially 
elevated and this discrepancy might reflect 
differences in the experimental strategy (15). In 
an analogous vein knockout of Kir6.1 in 
vascular smooth muscle cells also did not affect 
the basal CPP. It is known that glibenclamide 
can inhibit basal coronary flow and it may be 
that combined inhibition of both vascular 
smooth muscle and endothelial KATP channels is 
necessary for this to occur (22,23).  
 Deletion of Kir6.1 doesn’t rule out the 
possibility of Kir6.1-Kir6.2 heteromultimers. To 
investigate this, we used an endothelial-specific 
Kir6.2 KO mouse and looked at whole-cell K+ 
current in aortic endothelial cells and CPP in 
isolated hearts. We found that the KATP current 
was largely unaffected in Kir6.2 eKO mice and 
the CPP was not significantly different at rest or 
during challenge with pinacidil and hypoxia. 
The previous study showing a Kir6.1\Kir6.2 
heteromultimer used a human cell line and it is 
possible there are species differences. For 
example, SUR1 is preferentially expressed in the 
atria of mice but this is not prominent in man 
(24,25).   
 One of the major gains of our tissue-
selective strategy is that it allows us to explore 
the contribution of the endothelial channel to 
whole animal cardiovascular physiology. One 
potentially important role was revealed when we 
studied the coronary circulation. In the coronary 
arteries of eKO mice, hypoxia-induced 
vasodilation was reduced by more than 65%. 
Though there was a trend for a reduction in the 
hypoxic response in coronary smooth muscle 
cells with Kir6.1 deletion it was not as 
pronounced as that for endothelial deletion. This 
suggests that the endothelial channel may be of 
preeminent importance as a hypoxic sensor in 
the coronary circulation. The pronounced 
changes in coronary perfusion pressure and loss 
in eKO mice may mean it is particularly 
important in resistance vessels. There was a 
trend for a reduction in coronary perfusion 
pressure with hypoxia in the smooth muscle 
knockout though this was not statistically 
significant.    
 We also challenged the hearts to a 
period of ischaemia reperfusion injury. In eKO 
hearts this led to a ~20 % increase in cardiac 
tissue death compared to littermate controls. 
These data support the idea that KATP channels 
in endothelium may have a protective role in 
times of metabolic stress. Specifically they may 
contribute together with the smooth muscle 
channel in matching blood flow to tissue 
metabolic demand and thus acting to preserve 
tissue. The co-operation of the smooth muscle 
channel in this response is supported by the 
increased tissue injury also seen in the smKO 
mouse. It is also possible that the endothelial 
channel might have a more general protective 
function on surrounding tissues through the 
release of endothelial mediators (26). Even more 
broadly some protective functions attributed to 
potassium channel openers on the heart may 
occur because of the activation of endothelial 
KATP channels (13). The endothelial channel is 
responsible as endothelial deletion of Kir6.1 
does affect smooth muscle KATP currents.  
 One of the major potential mediators in 
the hypoxic response is the local release of 
adenosine from metabolically challenged tissue. 
It has been suggested for some time that channel 
activation occurs as much through hormonal 
regulation via adenosine receptors as direct 
metabolic sensitivity of the KATP channel 
complex (27). It is known that the vascular KATP 
channel can be activated by signalling coupled 
to the stimulatory G-protein and downstream 
activation of adenylate cyclase and protein 
kinase A (28-32). Subsequent studies in 
heterologous expression systems identified 






































SUR2B subunits responsible for direct protein 
kinase A phosphorylation (33,34). There is some 
disagreement as to the exact adenosine receptor 
responsible for the signalling but it is known that 
A2A and A2B both couple to the stimulatory G-
protein and activate protein kinase A signalling 
(30,35). However less is known about KATP in 
endothelial cells (14). Our data show that a non-
specific adenosine agonist (NECA) can activate 
K+ currents in endothelial cells and this is 
abrogated in eKO endothelial cells. Furthermore, 
the response of coronary artery blood vessels to 
NECA is also impaired, consistent with 
impaired regulation of the endothelial KATP 
channel.   
 A key question remains: how do 
endothelial cells couple to smooth muscle cells 
and what is the role of the KATP channels in that 
coupling? We have shown that activation of the 
channel leads to Ca2+ entry which is a 
prerequisite for endothelial mediator release (36). 
Given the extensive work of others we do not 
think that these channels necessarily contribute 
to the release of K+ acting as an endothelial 
hyperpolarising factor (37,38). The other issue is 
that the particular set of mediators is likely to 
vary with vascular bed and the nature of the 
vessel whether it be conduit or resistance. The 
exact delineation of this is best addressed by 
separate studies.   
 In conclusion we have established the 
identity of an endothelial KATP channel and 
shown that it can influence Ca2+ entry into the 
cells. The endothelial KATP channel in the 
coronary circulation plays an important role in 
vasodilatation to hypoxia and limiting ischaemia 
reperfusion injury in the heart.  
 
EXPERIMENTAL PROCEDURES 
Animal husbandry - All experiments were 
conducted in accordance with the Guide for the 
Care and Use of Laboratory Animals published 
by the British Home Office regulations (covered 
by project licences PPL/6732 and PPL/7665) 
and by the US National Institutes of Health 
(NIH Publication No. 85-23, revised 1996). 
Generation of the endothelium-specific Kir6.1 
mouse strains - Kir6.1(+/flx) mice were 
previously generated in our laboratory in 
collaboration with Genoway (Lyon, France; 
project number genOway/EV/TIN1- Kcnj8 
070206), the detailed method has been described 
previously (5). Endothelium-specific Kir6.1 KO 
mice were generated by crossing endothelium 
Tie-2 promoter driven cre-transgenic mice (tie2 
cre, http://jaxmice.jax.org/strain/004128.html) 
with Kir6.1 homozygous floxed (Kir6.1(flx/flx)) 
mice. A further cross of the offspring resulted in 
genotypes of tie2cre+ Kir6.1(flx/flx) (eKO) and 
littermate controls. Similarly, smooth muscle-
specific Kir6.1 KOs (smKO) were generated by 
crossing Kir6.1(flx/flx) mice with mice 
expressing a sm22 promoter driven cre to give 
sm22 cre+ Kir6.1 (flx/flx) mice. Littermate 
controls are referred to as wildtype mice below. 
Generation of the endothelium-specific Kir6.2 
mouse strains - Kir6.2 (+/flx) mice were 
generated by the IMPC (Harwell). Detailed 




The conditional floxed allele (tm1c) was 
generated from the targeted KO first allele (tm1a, 
with a reporter-tagged insertion with conditional 
potential) by flp-mediated excision of the 
reporter tag and neomycin selection cassette. 
Kir6.2 floxed mice were crossed with 
endothelium Tie-2 promoter driven cre-
transgenic mice to generate tie2cre+ Kir6.2 
(flx/flx) (Kir6.2 eKO) and littermate controls. 
Genotyping - Genomic DNA was prepared from 
ear biopsies for genotyping by PCR using 
standard cycling parameters. The Kir6.1 floxed 
allele was identified using the following primers: 
sense 5’-
ACTAGCACCTCTATCCCCAGCTCCTACC-
3’ and antisense 5’-
CCGCCCCTCCCTCTGAACCTATATC-3’ 
yielding WT bands of 458 bp and floxed allele 
bands of 600 bp. The presence of the cre 
recombinase gene in the Kir6.1 endothelium-
specific KO line was determined using the 




yielding a band of 512 bp in cre positive mice 
and no band in cre negative mice. The presence 
of the cre recombinase gene in the Kir6.1 
smooth muscle-specific knock-out line was 
determined using the following primer set: sense 
5’-CCAATTTACTGACCGTACACC-3’ and 
antisense 5’-GTTTCACTATCCAGGTTACGG-
3’ yielding a band of 900 bp in cre positive mice 
and no band in cre negative mice. Both the 
floxed and cre PCRs used Taq polymerase (NEB, 
UK).The presence of the WT and Kir6.2 floxed 
alleles was detected using the following primer 
sets: WT (110 bp band); sense 5’-
CTGTCCCGAAAGGGCATTAT-3’ and 










































Quantitative real-time PCR (qRT-PCR) - The 
RNAeasy kit (Qiagen, UK) was used to extract 
the total RNA from mouse tissues, treated with 
DNase I and reverse-transcribed using the high 
capacity cDNA reverse transcription kit 
(Applied Biosystems, UK). cDNA (50 ng) was 
used for qRT-PCR, which was performed using 
customised Taqman gene expression assays 
(Applied Biosystems, UK). Commercially 
available probes (Life Technologies Ltd, UK) 
were used for all KATP channel subunit genes as 
listed below: Mm00434620_m1 for Kcnj8 
(Kir6.1), Mm00440050_s1 for Kcnj11 (Kir6.2), 
Mm01701349_m1 for Abcc8 (SUR1), and 
Mm00441638_m1 for Abcc9 (SUR2). Each gene 
was assayed in triplicate and relative expression 
was calculated by using the comparative CT 
method normalised to GAPDH. Aortas were 
denuded with forceps and mesenteric arteries 
with course horse hair. Data are presented as a 
relative change compared to WT + endothelium. 
Ca2+ imaging of aortic valve leaflets - To assess 
the intracellular calcium concentration in the 
cytosol of endothelial cells ([Ca2+]i), aortic valve 
leaflets from the mouse heart were dissected out, 
mounted into a custom-made glass bottomed 35 
mm petri dish (MatTek, USA) and placed in 
HEPES buffer of the following composition 
(mmol/L): HEPES 10, NaCI 140, KCI 5, 
Glucose 10, CaCI2 1, pH 7.4 (18). The valves 
were then incubated with the Ca2+ indicator 
Fluo-4 (2 µmol/L) in HEPES buffer at room 
temperature for 2 hours followed by a wash with 
indicator-free buffer for 30 minutes. The valve 
leaflets were imaged on a Zeiss LSM510 
confocal microscope. Changes in Fluo-4 
fluorescence following experimental 
interventions were normalized to the value at the 
beginning of each experiment (F0). 
Measurement of coronary perfusion pressure - 
The Langendorff isolated perfused heart system 
was used to measure basal coronary perfusion 
pressure (CPP) and the effects of the KATP 
channel opener pinacidil and blocker 
glibenclamide and in hypoxic and ischaemic 
conditions. Briefly, mice were injected with 
heparin sodium (250 IU) and anaesthetised 
with a combination of ketamine/xylazine. The 
hearts were rapidly excised and placed in ice-
cold Krebs-Henseleit solution (containing in 
mmol/L: NaCl 118, KCl 4.75, KH2PO4 1.19, 
NaHCO3 25, MgSO4.7H2O 1.19, CaCI2 1.4, Na 
Pyruvate 2 and glucose 10) equilibrated with 95% 
O2/5% CO2, pH 7.4. The aorta was located and 
cannulated with a 20-gauge aortic cannula. 
Hearts were placed on the Langendorff system 
and retrogradely perfused with Krebs solution 
under constant flow at 2 mL/min at 37ºC. 
Spontaneously beating hearts were allowed to 
stabilise for 30 mins with CPP measured 
continuously via a pressure transducer 
connected to a data acquisition system 
(Powerlab 5, AD instruments) and visualised on 
LabChart 8 (Powerlab 5, AD instruments). 
Following stabilisation, hearts were subjected to 
drug challenge (constant perfusion), hypoxia 
(Krebs bubbled with 95% N2/5% CO2) or global 
ischaemia and reperfusion (no flow for 30 
minutes followed by 60 minutes reperfusion) 
(39,40). In these experiments the investigators 
were blinded to genotype until the analysis was 
complete. 
Quantification of infarct size with 2, 3, 5-
triphenyltetrazolium chloride (TTC) staining - 
Hearts were frozen for 10 minutes prior to being 
sliced into 1 mm thick transverse sections using 
a heart cradle and razor blades. Sections were 
placed in 1% (in PBS) TTC and incubated at 
37oC for 15-20 minutes. Sections were then 
placed in a Perspex envelope and scanned. The 
infarct size of stained hearts was quantified 
using ImageJ software. In these experiments the 
investigators were blinded to genotype until the 
analysis was complete. 
Isolation of aortic endothelial and smooth 
muscle cells and patch-clamp electrophysiology 
- To isolate endothelial cells, mice were killed 
by cervical dislocation, aortas removed and 
placed in ice-cold Ca2+-free physiological saline 
solution (PSS) containing (mmol/L); NaCl 125, 
KCl 4.8, KH2PO4 1.2, EDTA 1.1, MgCI2 1.7, 
EGTA 1, HEPES 10, and glucose 11, pH 7.4. 
Vessels were cleaned of fat and connective 
tissue and cut into rings and treated with 
2mg/mL collagenase type II (Worthington) in 
low-Ca2+ PSS (containing in mmol/L); NaCl 136, 
KCl 5.6, NaHCO3 4.17, NaH2PO4 0.44, 
Na2HPO4 0.42, MgCI2 10.47, CaCl2 0.1, HEPES 
10, pH 7.4) for 10 minutes at room temperature 
followed by 20 minutes at 37ºC. Rings were 
washed with Ca2+-free PSS, slit open and single 
endothelial cells were obtained by gentle 
trituration. Smooth muscle cells were isolated 
from endothelium-denuded aorta by treating 
with 0.7 mg/mL papain, 0.25 mg/mL BSA, 0.5 
mM DTT in low calcium dissociation medium 
(containing (mM); 125 NaCl, 5 KCl, 0.1 CaCl2, 






































NaH2PO4, 10 Glucose, 10 HEPES, pH 7.2 with 
NaOH) with shaking at 37 C for 15 minutes 
followed by 15 minutes incubation in 
dissociation solution containing 0.5 mg/mL 
collagenase and 0.25 mg/mL BSA. Tissue was 
subsequently washed in enzyme-free 
dissociation solution and gently triturated. Cells 
were kept on ice and placed directly into the 
recording chamber 5 minutes prior to use. 
Whole cell patch-clamp recordings were 
performed as described previously (41). Whole-
cell currents were amplified by an Axoclamp 
700, low-pass filtered at 1 KHz (4 pole Bessel) 
and sampled at 5 kHz using a Digidata 1440 
(Axon Instruments). Currents were acquired and 
analysed using pClamp10 (Axon Instruments). 
Whole-cell currents were recorded using a ramp 
protocol (-150 to +50 mV for 1 s from holding 
potential of -80 mV). Mean current-density 
values were taken at +40 mV. The pipette 
solution contained (mmol/L); KCl 107, MgCl2 
1.2, CaCl2 1, EGTA 10 and HEPES 5 with 
MgATP 0.1 and NaADP 1, pH 7.2 using KOH. 
The bath solution contained (mM); 110 NaCl, 5 
KCl, 1.2 MgCl2, 1.8 CaCl2, 10 Glucose, 10 
HEPES (pH 7.2). 
Reagents - Pinacidil and glibenclamide were 
purchased from Sigma-Aldrich. NECA was 
obtained from Tocris. All the reagents for the 
extracellular and intracellular solutions were 
from Sigma-Aldrich. 
Statistical analysis - Data are presented as mean 
± S.E.M. Data were analysed using Microsoft 
Excel (Microsoft) and GraphPad Prism. 
Student’s t test and ANOVA were used to 
compare means where appropriate. P≤0.05 was 
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Figure 1. Generation and characterisation of the endothelium-specific knockout mouse (eKO). 
A,  Cre-LoxP targeting strategy for the deletion of exon 2 of the Kcnj8 gene. A targeting vector 
construct for Kcnj8 with a 5’ LoxP site together with a FRT-flanked neomycin (Neo) selection 
cassette within intron 1 upstream of exon 2 and the second loxP site in intron 2 and diptheria toxin A 
(DTA) negative selection marker downstream. Mice with the recombined Kcnj8 locus were crossed 
with global flp-deleter mice to allow Flp-mediated excision of the neomycin selection cassette and 
generate Kir6.1 (+/flx) offspring. Kir6.1 (flx/flx) mice were then crossed with mice in which the Cre 
recombinase expression is driven by an endothelium-specific promoter associated with the Tie2 
receptor to produce tie2cre+  Kir6.1(flx/flx) (eKO) mice. B, Genotyping of DNA isolated from tail for 
the floxed alleles (top) and Cre recombinase (bottom). Relative levels of expression of Kir6.1, Kir6.2 
and SUR2 in the aorta (C) and mesenteric arteries  (D) with intact endothelium (+E) and with 
endothelium denuded (-E) from WT and eKO mice. No CT values were detectable for SUR1. The 
gene expression level in each case was normalized to the WT + endothelium (WT+E). Data is shown 
as mean ± S.E.M, n=6 mice, **P<0.01, ***P<0.001 compared to WT+E. 
 
Figure 2.  Endothelial-specific Kir6.1 deletion results in an attenuated  K
ATP
 current in aortic 
endothelial cells. Representative time-course traces at +40 mV (right panel)  and whole-cell current 
density-voltage traces (left panel) taken from ECs isolated from WT (A) and eKO  (B) mice showing 
the effects of pinacidil (Pin) and glibenclamide (Glib). The control (Con) trace is shown in grey. 
Current-voltage relationships were recorded using a 1s ramp protocol (-150 mV to +50 mV) from a 
holding potential of -80 mV. C, Summary of the mean current-densities at +40 mV from ECs isolated 
from WT (left) and eKO (right) mice. D, Mean glibenclamide-sensitive current in ECs from WT and 
eKO mice. n=8-20 cells from 4-9 mice. Representative (E) and mean data (G and H) of whole-cell 
currents recorded from SMCs isolated from WT and eKO mice. n=10-20 cells from 4-9 mice. Data is 
shown as mean ± S.E.M.  *P<0.05, **P<0.01, ***P<0.001 compared to control/WT. 
 
Figure 3. Pinacidil-induced elevation of cytosolic [Ca2+] is attenuated in eKO mouse aortic 
valves. A, Confocal images showing a pinacidil-evoked concentration-dependent elevation in 
cytosolic [Ca2+] in WT mice. 100 μM CPA (SR uptake inhibitor) was used as a control to induce an 
increase in cytosolic at baseline. B, Confocal images showing the effect of CPA and pinacidil on 
cytosolic [Ca2+] in valves from eKO mice. Scale bar represents 25 µm. C, Summary time-course 
traces (S.E.M in the dashed lines) illustrating the effects of 100 μM CPA, 10 and 100 μM pinacidil 
and 10 μM glibenclamide on cytosolic [Ca2+] aortic valve cells from WT (black) and eKO (grey) 
mice. Changes in cytosolic [Ca2+] are expressed as relative fluorescence ratio, F/F0. D, Bar graph 
showing the mean data from traces in panel C. Data is shown as mean ± S.E.M, n=6 mice, *P<0.05, 
***P<0.001 compared to WT. +++P<0.001 compared to WT 10 µM pinacidil. 
 
Figure 4. Kir6.1 containing K
ATP
 channels are present in both endothelium and smooth muscle 
of the coronary circulation. A, Mean basal coronary perfusion pressure (CPP) in eKO and smKO 
mice and their littermate controls (n=9-23). CPP was measured using the Langendorff set-up under 
constant flow. B, Representative CPP traces from Langendorff hearts from eKO, smKO mice and 
their littermate controls (WT-top panel and KO-lower panel) in response to 10 μM pinacidil and 10 
μM glibenclamide. C, Summary of the mean change in CPP (relative to baseline) of WT and eKO 
mouse hearts in response to 10 μM pinacidil and 10 μM glibenclamide. Data is shown as mean ± 
S.E.M, n=5-10 mice, *P<0.05, **P<0.01 compared to WT. 
 
Figure 5. Endothelial K
ATP
 channels containing Kir6.1 may be protective during metabolic 
challenge. A, Mean CPP of eKO and smKO mouse hearts and hearts from their respective littermate 




) (n=6-10). CPP was 
measured using the Langendorff set-up under constant flow. Representative sections (left) and mean 






































and smKO (C) mouse hearts stained with 1% TTC, pale tissue signifies infarction. Data is shown as 
mean ± S.E.M, n=5-16 mice, *P<0.05, **P<0.01 compared to WT.  
 
Figure 6. Ablation of Kir6.2 does not attenuate K
ATP
 current in aortic ECs and is not protective 
in IR injury. A, Representative time-course traces at +40 mV taken from ECs isolated from WT (left) 
and Kir6.2 eKO (right) mice showing the effects of pinacidil (Pin) and glibenclamide (Glib). Currents 
were elicited using a 1s ramp protocol (-150 mV to +50 mV) from a holding potential of -80 mV. B, 
Summary of the mean current-densities at +40 mV from ECs isolated from WT (left) and Kir6.2 eKO 
(right) mice. C, Mean glibenclamide-sensitive current in ECs from WT and Kir6.2 eKO mice. n=9-14 
cells from 3 mice. D, Mean basal CPP of WT and Kir6.2 eKO mouse hearts (n=10-13). CPP was 
measured using the Langendorff set-up under constant flow. E, Mean change in CPP (relative to 
baseline) in the presence of pinacidil, glibenclamide and hypoxia of WT and Kir6.2 eKO hearts (n=5-
7). F, Representative sections (left) and mean infarct size (right) following 30 minutes of  global 
ischemia and 60 minutes of reperfusion of WT and Kir6.2 eKO mouse hearts stained with 1% TTC, 
pale tissue signifies infarction (n=11). Data is shown as mean ± S.E.M.  ***P<0.001 compared to 
control. 
 
Figure 7. Effect of the adenosine agonist NECA is reduced in aortic ECs and the coronary 
circulation of eKO mice. A, Representative time-course traces at +40 mV taken from ECs isolated 
from WT (left) and eKO (right) mice showing the effects of NECA. B, Representative current-voltage 
traces from a WT (left) and eKO (right) cell in the presence and absence of NECA. Currents were 
elicited using a 1s ramp protocol (-150 mV to +50 mV) from a holding potential of -80 mV. C. 
Summary of the mean current-densities at +40 mV from ECs isolated from WT (left) and eKO (right) 
mice. n=8-9 cells from 3 mice. D, Representative CPP traces from Langendorff hearts from WT and 
eKO mice challenged with NECA and glibenclamide. E, Mean change in CPP (relative to baseline) of 
WT and eKO mouse hearts in the presence of NECA (n=6-10). CPP was measured using the 
Langendorff set-up under constant flow. Data is shown as mean ± S.E.M. *P<0.05, **P<0.01 
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